JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 20, 2005; DOI: 10.1124/jpet.105.097618


0022-3565/06/3171-292-299$20.00
JPET 317:292-299, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.105.097618v1
317/1/292    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rezazadeh, S.
Right arrow Articles by Fedida, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rezazadeh, S.
Right arrow Articles by Fedida, D.

NEUROPHARMACOLOGY

KN-93 (2-[N-(2-Hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor, Is a Direct Extracellular Blocker of Voltage-Gated Potassium Channels

Saman Rezazadeh, Thomas W. Claydon, and David Fedida

Department of Cellular and Physiological Sciences, University of British Columbia, Vancouver, British Columbia, Canada

The effect of Ca2+/calmodulin-dependent protein kinase II (CaMK II) on voltage-gated ion channels is widely studied through the use of specific CaMK II blockers such as 2-[N-(2-hydroxyethyl)]-N-(4methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine (KN-93). The present study demonstrates that KN-93 is a direct extracellular blocker of a wide range of cloned Kv channels from a number of different subfamilies. In all channels tested, the effect of 1 µM KN-93 was independent of CaMK II because 1 µM2-[N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine, phosphate (KN-92), an inactive analog of KN-93, caused similar inhibition of currents. In addition, dialysis of cells with 10 µM CaMK II inhibitory peptide fragment 281-301 (CIP) had no effect on current kinetics and did not prevent the inhibitory effect of KN-93. The IC50 for block of the Kv1.5 channel (used as an example to determine the nature of KN-93 block) was 307 ± 12 nM. KN-93 blocked open channels with little voltage dependence that did not alter the V1/2 of channel activation. Removal of P/C-type inactivation by mutation of arginine 487 to valine in the outer pore region of Kv1.5 (R487V) greatly reduced KN-93 block, whereas enhancement of inactivation induced by mutation of threonine 462 to cysteine (T462C) increased the potency of KN-93 by 4-fold. This suggested that KN-93 acted through promotion and stabilization of C-type inactivation. Importantly, KN-93 was ineffective as a blocker when applied intracellularly, suggesting that CaMK II-independent effects of KN-93 on Kv channels can be circumvented by intracellular application of KN-93.


Received October 24, 2005; accepted December 15, 2005.

Address correspondence to: Dr. David Fedida, Department of Cellular and Physiological Sciences, 2350 Health Sciences Mall, Vancouver BC V6T 1Z3, Canada. E-mail: fedida{at}interchange.ubc.ca




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Werdich, E. A. Lima, I. Dzhura, M. V. Singh, J. Li, M. E. Anderson, and F. J. Baudenbacher
Differential effects of phospholamban and Ca2+/calmodulin-dependent kinase II on [Ca2+]i transients in cardiac myocytes at physiological stimulation frequencies
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2352 - H2362.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Lamsa, E. E. Irvine, K. P. Giese, and D. M. Kullmann
NMDA receptor-dependent long-term potentiation in mouse hippocampal interneurons shows a unique dependence on Ca2+/calmodulin-dependent kinases
J. Physiol., November 1, 2007; 584(3): 885 - 894.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. J. Urbano, E. Leznik, and R. R. Llinas
Modafinil enhances thalamocortical activity by increasing neuronal electrotonic coupling
PNAS, July 24, 2007; 104(30): 12554 - 12559.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-J. Qu, V. E. Bondarenko, C. Xie, S. Wang, M. S. Awayda, H. C. Strauss, and M. J. Morales
W-7 modulates Kv4.3: pore block and Ca2+-calmodulin inhibition
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2364 - H2377.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. Szabo, M. J. Urbanski, T. Bisogno, V. D. Marzo, A. Mendiguren, W. U. Baer, and I. Freiman
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol
J. Physiol., November 15, 2006; 577(1): 263 - 280.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.